Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
2025 Global Female Infertility Diagnosis And Treatment Market Industry (2031 Outlook)
... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More
-
Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
... Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge ... Read More
-
2025 Global Gas Chromatography Based Cannabis Analysis Market Industry (2031 Outlook)
... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
Xerostomia (Dry Mouth) Therapeutics
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Over-the-Counter, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$603.6 Million by the end ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the end ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2024-2030. HIV, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end of the ... Read More
-
Interventional Oncology Devices
... at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Osseointegration Implants
... CAGR of 7.2% over the analysis period 2024-2030. Knee Implants, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$5.1 Billion by the end of the analysis ... Read More
-
Orthopedic Bone Cement
... at a CAGR of 4.9% over the analysis period 2024-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$944.8 Million by the ... Read More
-
Patient Monitoring Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the end of ... Read More
-
Prosthetics and Orthotics
... at a CAGR of 5.0% over the analysis period 2024-2030. Orthotics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$7.5 Billion by the end of the ... Read More
-
Antacids
... 2.2% over the analysis period 2024-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Orthopedic Digit Implants
... at a CAGR of 5.3% over the analysis period 2024-2030. Metatarsal Joint Implants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$202.2 Million by the end ... Read More
-
Periodontal Therapeutics
... CAGR of 8.6% over the analysis period 2024-2030. Systemic Antibiotics, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$623.3 Million by the end of the analysis ... Read More
-
Radiation Therapy Equipment
... at a CAGR of 6.6% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.1 Billion by the ... Read More
-
Corticosteroids Therapy
... CAGR of 4.6% over the analysis period 2024-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.1 Billion by the end of the analysis period. ... Read More
-
Eye Allergy Therapeutics
... at a CAGR of 5.5% over the analysis period 2024-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing
... Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$1.5 Billion ... Read More
-
Anti-Allergy Drugs
... CAGR of 7.1% over the analysis period 2024-2030. Pharmacies, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$35.4 Billion by the end of the analysis period. ... Read More
-
Cancer Biomarkers
... CAGR of 16.9% over the analysis period 2024-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of the analysis ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Cardiovascular and Soft Tissue Repair Patches
... reach US$8.3 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. ePTFE, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$5.0 ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by the ... Read More
-
Skin Tightening
... CAGR of 6.2% over the analysis period 2024-2030. Radio Frequency Skin Tightening, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$3.3 Billion by the end of ... Read More
Research Assistance
